{"ticker": {"uuid": "d85ca1fd-e63e-4c3b-bf59-31c3d1b549a6", "symbol": "CLOV", "name": "Clover Health Investments Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Healthcare Plans"}, "articles": [{"title": "Issuer (NASDAQ: CLOV) plans 10,192-share Class A sale under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSm1fSDByN2VISDBva3RlT3lKaks0WTJsdGF4ZTJjbU0wWHRvRmlzQktZZmFncGNWZXBPTzUzaHc3M21jZ0NSUnNydXBrRVRFT1pqLV82MFkwakRqTjdQMkdDSjVaU0hIQWFwMjlqblZQZ2VmUnNyWHpkTzBMczdpNXFoMXpjb1liZUhWNTNSb2RId2IyYlpWUUNnSUpsbmdMZy1haUxLR2xhR3dPTUdR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:42:10+00:00", "published_display": "15 Jul 2026 21:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sale of 12,712 shares planned in CLOV (Nasdaq: CLOV) notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQYnZFVGZnamJMMDhFcmxOQXZzNnRCcjB2c21SeTNGSjNUNmI4NERiSkdzT2tpRlN3N2czbEFQVUxkaXVBRGtMbzNtTVgxVFpBQUstc2VjQ1I4Q0x5Tkp6bHMzM014M1JiRWVVMUhHNlMwc0Njdzc5ZEFKNk51TF81d1NpbDk2MUptWDFvOWhfcHRIT0pkcEF2cVhycHpsd2pwSHNNRWVkcmI2SndqS2dz?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:38:14+00:00", "published_display": "15 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLOV (Nasdaq: CLOV) plans Rule 144 sale of 60765 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNZUZ1SjhqRkVzTjllZTFyakRBTl9OSjM4T1dleDd5Nk1yanRVYkhGWlVLOUxlTExxMFQ0WmNSRWZwbklSRVd0eTlsd2EtYTNnT3BVcGZhazRqVURNdVF2MVEwTHFjWG5oT0RpNE5zelR6V0p6NmFNYW9LYmt1LWdJdklRQVp6bDVaTXhDR1djSnd0SWVRRFNiSGVtaWR2a3dNMFBwcFJEM0lCNVZUbVpR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:31:00+00:00", "published_display": "15 Jul 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Grab Stock And 2 Penny Stocks With Strong Financial Health", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T13:43:40+00:00", "published_display": "13 Jul 2026 13:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments (CLOV) Faces A Valuation Test Ahead Of August Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcS1wa28ycjl4MFVvX0JDVjQ0Nzl4T1lob0dMMENkdTVCV2lWdjY5WlZwNHA0blRSaVNHTC1JdzY1b1lJUW9fd2VGRGJDbzYwZG5BRXY5VXpySkhhZFdSZTFfa1NiNGYzbVhKazQ4S05qd0FsTE45N05ITy1pdXY4U2VNU0FmVTM3eFZpMGIwWUpRRVZfWXQ1Y01tcGJROUFpRENV?oc=5", "source_name": "Market source", "published_at": "2026-07-11T05:16:03+00:00", "published_display": "11 Jul 2026 05:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Clover Health Investments (CLOV) Reasonable After Its 3.8x Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYzZDMUkxLWNSQ3JhRmY0SFpDdE9wQlBfN2I2UzJXN1dfWVRWMlBSR1hsVFl1MVltX3IxMVR3RDgwRXFYbG9Ha3FCV2RxR1hIUTRmOXBkbXNxRXFjRy1YUXkzZzNnMVdpZ2NzOC1Gdi02Yl9HS2xBMUJZVHd0V09VRnBZbFY3bFNTcVQ3NUtrRDNJeDlYLUl3QWUxd2ZXNi1BUVhrSWtUd2sxQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-10T12:15:13+00:00", "published_display": "10 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Medicare Advantage CEO sells $11,157 in shares", "summary": "Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 2,384 shares of the company's Class A Common Stock for a total of $11,157 on July 8, 2026. This transaction was part of a pre-arranged trading plan. Following the sale, Reynoso sti", "url": "https://www.investing.com/news/insider-trading-news/clover-health-medicare-advantage-ceo-sells-11157-in-shares-93CH-4784970", "source_name": "Investing.com", "published_at": "2026-07-09T21:45:44", "published_display": "09 Jul 2026 21:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/clover-health-report-second-quarter-200500383.html", "source_name": "GlobeNewswire", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health sets Aug. 5 webcast for second-quarter results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPaTZlc1UxQjNSM0ZyMjhqaUNpZVVNSGl4T21ETDluSjZSbm9HWGJSVkMybVNROTFoVkU4LXFET293ckJKaFEwUlA5eXlTTnlwOTF0VUV3Rlo3RVZaWFozd3BLUnl2eDdCU3lGUFYxVU9qZ2tDU3ZGOU4zNU1OTHhSdndBWTVldWhpdDJfeWlVemhuMGtTd1JyWk5XaVR5RWZVV214TGlWX2VRRUhFeFRLckN6cGxNQ0tNTzdZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) Medicare Advantage CEO sells small stake under Rule 10b5-1 plan", "summary": "Clover Health Investments, Corp. CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,384 shares of Class A Common Stock at $4.68 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026, and leaves Reynoso with 2,832,598 sh", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-e8cffac469f3.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:45:44", "published_display": "09 Jul 2026 20:45", "sentiment": "negative", "sentiment_pct": 40, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Ignore The Insider Selling In Clover Health Investments", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOS3VLOGsyWFY3Y2xycnNZMWkxZ25ZOXRTSmYtOHhxbEY4SDRZS3hfWDdsNFM0OGI3UW1JM2NmX2w4cnpCT0ZNSmUtQXJ4UlJfV1lYM2hhNGxWUWxIZHpBeXhiQlRPZlEtWEtvUVp6WS1kaFNrQXQ3M0hRVlNJSy05SGYxOVJjcGZWaGZJZ0FORnRfYUtqSkdsNzVvc3BnMUJGX0F6SFpTV3k0Vko1ZUF5TG1Pb1phSVA4dEEzSTBRdDBYbVZjUnQ0T3VvaXFNQWlweGdLczYzRmRuX21rSC0w0gHkAUFVX3lxTE9BXzVyeExyR3NqVW9Objk3Y19SX3RpbmV3bHNnbGNIb0VrSy10Ul9jVlMteUtxWlh3Ni0zOGRwMGJWQlF5NkljQWgzR19tdExzQ0RWd2ZSX3hXMFNXTXVBNWVHbjJMMnhWbjFxZE83OHIxTFpxSzRhYkE1NV80SXZQUTdPb0NwQm9LUGhxcGM2cHp1enJDYUF6MlJIZ0lUb3Q4RThFWW92cUtCRXpaaWZsR0dHU0N4T2p1ZzFJQkExOFVWSzVKS3ByMU1Kc0NPeDR1M0l2bUF3VXdYN3FISldnc3hPRA?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.", "summary": "", "url": "https://finance.yahoo.com/m/70ae2e15-e70c-375b-913f-a21c367aba47/clover-health%27s-ceo-sold.html", "source_name": "Motley Fool", "published_at": "2026-07-07T00:52:01+00:00", "published_display": "07 Jul 2026 00:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jamie Reynoso 10b5-1 sales listed in CLOV Form 144 (CLOV)", "summary": "A recently filed Form 144 for Clover Health Investments, Corp. (CLOV) details multiple 10b5-1 sales by Jamie Reynoso. The filing, dated July 6, 2026, lists sales on March 18, 2026, June 11, 2026, June 15, 2026, and June 17, 2026, along with Restricted Stock Units dated July 3, 20", "url": "https://www.stocktitan.net/sec-filings/CLOV/144-clover-health-investments-corp-de-sec-filing-5d96f1e68ce5.html", "source_name": "Stock Titan", "published_at": "2026-07-07T01:12:10", "published_display": "07 Jul 2026 01:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) exec sells 6,229 shares in mandated tax-withholding trade", "summary": "Jamie L. Reynoso, CEO of Medicare Advantage for Clover Health (CLOV), sold 6,229 shares of Class A Common Stock at $5.26 per share. This transaction was not a discretionary trade but a \"sell to cover\" action to meet tax withholding obligations related to the vesting of restricted", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-1fedc3a28371.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:36:54", "published_display": "07 Jul 2026 00:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Medicare Advantage CEO Reynoso sells $32,764 in stock", "summary": "Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 6,229 shares of Class A Common Stock for $32,764 on July 6, 2026. This sale was a \"sell to cover\" transaction to fulfill tax withholding obligations tied to the vesting of restricted stock units", "url": "https://www.investing.com/news/insider-trading-news/clover-health-medicare-advantage-ceo-reynoso-sells-32764-in-stock-93CH-4777821", "source_name": "Investing.com", "published_at": "2026-07-06T22:39:54", "published_display": "06 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS Nearly Doubles Its Price Target on Clover Health (CLOV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPekhSeDBZU1dwaVJHZ3VzY193RVRVejROOWp5V3VSVXVJNU9iN0dNNTBaaTNoX0NyVFpIaHhNZ3RBRjhQclpKRjlydU5seVo2RmhOOEV6YzNUMEJRU1JsNnRJTUdxNS16S1VOZ1F3TjhCSkpmRHNoTUt5YlF1R05iRmRvUWlhN3c4WkR4a3ZWZUs5aG5jbHpB?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments (CLOV) Q1 Beat And Guidance Raise Put Valuation Back In Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Clover Health (NASDAQ:CLOV) And Health Insurance Providers Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQWjA4Rm1nS3Zwa0xJTkI4ckF6NHUyUzNHTFNEdzhJdHlRVDE2RGdUalpxaDExNVVCUHc0Yi1Mc3Q5MmJtQ1oxNFJDTG84ZVlzcUk4VFc5NTZtN0JlX1Q4S01MQ3hwM2FYV3VHSFpGeHBqUDlUbFhNRGgtZzBDbGltUzRaQWhGLW9SQVBaZ2hkeElZQ1FqQzkwck53cFhOYms?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) CEO\u2019s 313,476-share sale tied to RSU tax withholding", "summary": "Clover Health Investments, Corp. (CLOV) CEO Andrew Toy sold 313,476 shares of Class A common stock at $5.32 per share. This sale was explicitly to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) and was a non-discretionary \"sell to c", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-8147846aeb02.html", "source_name": "Stock Titan", "published_at": "2026-07-02T00:40:29", "published_display": "02 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Andrew Toy sells $1.67 million in stock By Investing.com", "summary": "Clover Health CEO Andrew Toy sold 313,476 shares of Class A Common Stock for $1.67 million to cover tax withholding obligations related to vested restricted stock units. This sale was a \"sell to cover\" transaction and not a discretionary trade. The stock, trading near its 52-week", "url": "https://ng.investing.com/news/stock-market-news/clover-health-ceo-andrew-toy-sells-167-million-in-stock-93CH-2583448", "source_name": "Investing.com Nigeria", "published_at": "2026-07-01T22:41:13", "published_display": "01 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Andrew Toy sells $1.67 million in stock", "summary": "Clover Health CEO Andrew Toy sold 313,476 shares of Class A Common Stock for $1.67 million to cover tax obligations related to restricted stock units. This sale was a mandatory \"sell to cover\" transaction and not discretionary. The company recently reported Q1 2026 revenue of $74", "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-andrew-toy-sells-167-million-in-stock-93CH-4771953", "source_name": "Investing.com", "published_at": "2026-07-01T22:40:29", "published_display": "01 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing", "summary": "This SEC filing details a Form 144 notice of proposed sale of securities for Clover Health Investments, Corp. (CLOV). The filing indicates an individual plans to sell 309,558 shares of Class A Common Stock, acquired through Restricted Stock Units as compensation, with an aggregat", "url": "https://www.stocktitan.net/sec-filings/CLOV/144-clover-health-investments-corp-de-sec-filing-033d45f7b7fa.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:39:12", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Clover Health Investments Corp. Class A Stocks", "summary": "This article provides a list of exchange-traded funds (ETFs) that hold Clover Health Investments Corp. Class A stocks. The funds are sorted by market value and include details such as issuer, management style, focus, expense ratio, assets under management (AUM), and price perform", "url": "https://www.tradingview.com/symbols/FWB-7QD/etfs/", "source_name": "TradingView", "published_at": "2026-06-30T20:09:39", "published_display": "30 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Clover Health (CLOV) Centralizing Home-Care Leadership Reveal a Deeper Shift in Strategy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLOV SEC Filings - Clover Health Investments Corp 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for investors to access Clover Health Investments (CLOV) SEC filings, including annual reports (10-K), quarterly reports (10-Q), and material event reports (8-K). It details recent insider transaction activity, such as share withholding", "url": "https://www.stocktitan.net/sec-filings/CLOV/", "source_name": "Stock Titan", "published_at": "2026-06-29T04:28:07", "published_display": "29 Jun 2026 04:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.", "summary": "", "url": "https://finance.yahoo.com/m/8f497b0a-a9d9-3007-9cd1-289260234486/a-clover-health-director-sold.html", "source_name": "Motley Fool", "published_at": "2026-06-27T17:33:01+00:00", "published_display": "27 Jun 2026 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "7QD Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast and price target for Clover Health Investments Corp. Class A (7QD) stock based on analyst opinions. It details maximum and minimum price estimates, historical price data, earnings information, and financial performance for the company, including re", "url": "https://www.tradingview.com/symbols/HAM-7QD/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T10:40:29", "published_display": "26 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments Corp. Class A Actuals & Estimates (NASDAQ:CLOV)", "summary": "This article provides an overview of Clover Health Investments Corp. (NASDAQ: CLOV), detailing its financial actuals and estimates. It covers the company's current stock price, historical highs and lows, market capitalization, and volatility. Additionally, it includes analysts' f", "url": "https://www.tradingview.com/symbols/NASDAQ-CLOV/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T02:42:00", "published_display": "26 Jun 2026 02:42", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments Corp. Class A Actuals & Estimates (BX:CLOV)", "summary": "This article provides financial actuals and estimates for Clover Health Investments Corp. Class A (CLOV) traded on the BX Swiss exchange. It details analyst price targets, upcoming earnings dates, past earnings and revenue figures, and confirms that CLOV does not pay dividends. T", "url": "https://www.tradingview.com/symbols/BX-CLOV/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T23:09:36", "published_display": "25 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health stock hits 52-week high at 5.18 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPYVlNeFhwdlNTR3RwN2UwNWRDREpkV0Jkcllkc0U4RzVFZkZNbHB3RjVwQ1o3dFZuOVBXdllaRnBHaE5Jd2s5eDhRcU1wNlE1LTZ3RWNtU0FQRUIzYWdpWGpCUWgxZmhjR254cUROWHllZUtTZGhjTFBrRFktd051ZVhNdVJVQVJONTRXVktmaUhqUTNDejE1b0NZeHpiXzhJbnZBTi05cw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV): 3 Reasons We Love This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORnFrd3YzeFFCWjc3TmdiMUhGRWJ4WHZTN2c4ejRhY0VjOUVTMlF3MFRTWGN6dmphODZ4bG44TWh2TDRieGNlblU2RE1PSEhlSUg0MExIdmt2TzBfckw3ZU1HMmlDVFNzdXVIRVNlalVrRElWZldWSlZVd3N2TFJuMUQyV2VHRzZEYkhhMzV0RjV2Nm83Q0tNaQ?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $11,280 in class A stock By Investing.com", "summary": "Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments, sold 2,360 shares of Class A Common Stock worth $11,280 on June 17, 2026, as part of a Rule 10b5-1 trading plan. This sale occurred while Clover Health shares have risen 104% year-to-date and are trading near ", "url": "https://m.au.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-11280-in-class-a-stock-93CH-4494523?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-19T05:40:42", "published_display": "19 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $11,280 in class A stock", "summary": "Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,360 shares of Class A Common Stock for a total of $11,280 on June 17, 2026, as part of a Rule 10b5-1 trading plan. This transaction occurred amidst a 104% year-to-date surge in Clover Health shares, leading to an", "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-11280-in-class-a-stock-93CH-4749420", "source_name": "Investing.com", "published_at": "2026-06-18T18:08:58", "published_display": "18 Jun 2026 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) executive sells 2,360 shares in 10b5-1 plan", "summary": "Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, sold 2,360 shares of Class A common stock at a weighted average price of $4.78 per share. This sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. Following th", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-2fbaac1f92bb.html", "source_name": "Stock Titan", "published_at": "2026-06-18T10:40:04", "published_display": "18 Jun 2026 10:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health VP of finance Oldakowski sells $58,815 in stock", "summary": "Joseph Frank Oldakowski, VP of Finance at Clover Health, sold 12,102 shares of Class A Common Stock for $58,815 on June 16, 2026. This transaction was a \"sell to cover\" to fulfill tax obligations for vesting restricted stock units (RSUs) and was not a discretionary trade. The sal", "url": "https://www.investing.com/news/insider-trading-news/clover-health-vp-of-finance-oldakowski-sells-58815-in-stock-93CH-4747244", "source_name": "Investing.com", "published_at": "2026-06-18T05:10:35", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health VP of finance Oldakowski sells $58,815 in stock By Investing.com", "summary": "Joseph Frank Oldakowski, VP of Finance at Clover Health, sold 12,102 shares worth $58,815 to cover tax obligations from vested restricted stock units. This \"sell to cover\" transaction was not discretionary and occurred as Clover Health's stock is up 110% year-to-date, trading nea", "url": "https://m.au.investing.com/news/insider-trading-news/clover-health-vp-of-finance-oldakowski-sells-58815-in-stock-93CH-4492373?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-17T14:10:42", "published_display": "17 Jun 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) finance VP sells 12,102 shares in tax-related RSU transaction", "summary": "Joseph Frank Oldakowski, VP of Finance and Controller at Clover Health, sold 12,102 shares of Class A Common Stock for $4.86 per share to cover tax withholding obligations related to the vesting of restricted stock units. This \"sell to cover\" transaction was mandatory and not a d", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-60e2e3918ead.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:10:42", "published_display": "17 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $29,273 in company stock By Investing.com", "summary": "Clover Health CEO Jamie Reynoso sold 6,350 shares of the company's Class A Common Stock for $29,273 to cover tax withholding obligations related to restricted stock unit vesting. Following the sale, Reynoso directly owns 2,843,571 shares. Despite the stock trading near its 52-wee", "url": "https://au.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-29273-in-company-stock-93CH-4489885", "source_name": "Investing.com Australia", "published_at": "2026-06-16T17:09:41", "published_display": "16 Jun 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health chief legal officer Karen Soares sells $21,579 in stock", "summary": "Clover Health's Chief Legal Officer, Karen Soares, sold 4,681 shares of the company's Class A Common Stock for a total of $21,579. These transactions were \"sell to cover\" to fulfill tax withholding obligations tied to restricted stock unit vesting, not discretionary trades. Follo", "url": "https://www.investing.com/news/insider-trading-news/clover-health-chief-legal-officer-karen-soares-sells-21579-in-stock-93CH-4744727", "source_name": "Investing.com", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) executive logs small tax-related sell-to-cover stock sale", "summary": "Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, sold 6,350 shares of Class A common stock on June 15, 2026, at a weighted average price of $4.61 per share. This sale was a non-discretionary \"sell to cover\" transaction to fulfill tax withholding ob", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-0139f8cc8af9.html", "source_name": "Stock Titan", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) legal chief sells 4,681 shares to cover taxes", "summary": "Clover Health Investments' Chief Legal Officer, Karen Soares, sold 4,681 shares of Class A common stock at a weighted average price of approximately $4.61 per share. This was a mandated \"sell to cover\" transaction to fulfill tax obligations related to vesting restricted stock uni", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-b9ac876d15cb.html", "source_name": "Stock Titan", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $29,273 in company stock", "summary": "Clover Health CEO Jamie Reynoso sold 6,350 shares of Class A Common Stock, totaling $29,273, to cover tax withholding obligations related to restricted stock units. This \"sell to cover\" transaction, occurring at a weighted average price of $4.61 per share, was not a discretionary", "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-29273-in-company-stock-93CH-4744728", "source_name": "Investing.com", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Court Win Lifts Clover Health Star Rating And Future Revenue Potential", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health stock jumps after Medicare rating upgrade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOM0Y0RjY1ZlJTNUJzeWlMbnpFSk5PdVl0NWRsM3ZqRHRlZFVocmlwS2xENnlGbmloTVFVcGNlY3MxdnQ0VTZKd29HdUozVk10WXdaRzdXQzZ1S25IX0xWV01vaTBzNk9JVTVHT0dTd0RVYU9qcnpmTTRhZ0JtdHN0dUxIa2hoX3MxeElIajBVYm91ZVhoWlpQVGE2UzVGVGVRWUlSUDUwWDJTSDBRWWg4dUhDR1p5WHBO?oc=5", "source_name": "Investing.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV)Hits Fresh Peak on Unexpected CMS Rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQX0VHQ0xBTUpwYlhJQW04QkRPWHpnZzhRZm9VM0RYZDFYYzJfMjAxVTZyMlRYeFVJN25YTEw5dXh2QjNocmtiazRGX2xrMmN0WVF6QjgyamMzeUNicENRQWdLbmpUUmRhX0xQbWxLclRpMFlSeGd3UGtaQkFjVVp3ZlV0aFhCczljYVB2cmgyNDdnN1BmWG9RMDNB?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover stock slips after robust Thursday gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOclhsV21iRUNkcmZFT09hREhHeG5WdG5CMjdkdGlYVkUySDNZQ0dVUEV4YWpVbEhDRng4dVRPM2F0T0wzZFZjNGhFbTcyT3UzbExRZFVOWlpfcENTdzhWVkl3MGVLRnN0QUdYR2tHaDlabkZZdUFHRUpjMU5EZ2hPSzZqVXhDSHlBVnhEUkRPTk41Z1dfMWd6OGxqeERsUDl5eUtjMHo1Sk5tU3FOaWVmOW1NUjJpU3JLSW16Zi01OVVyVVhiN21rN3E0U3B0MHNZdFEyMDMxLVBOT3IxWEFJ?oc=5", "source_name": "Nashville Post", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments And 2 Other Insider Picks For Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONkFGQmZld3ctd0tDYkNQY3JZMFYzS2FHaTFueThreVJxdmFMZThfa2FOZkctSFRwVWhubjkybGxiWEJ6c0tsQ0RlZk94OGhRNXlUZUh5QmdJS1VkQWU4MDU5QkVUOW1yQzB0SjFxYW53dk9UbnFTdmpxSE1hTzk2Z25LT3JncnJMblBhZ3phc0ExVlJNdUhPLWVFRWoxdEE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Clover Health Investments (CLOV) Share Surge Left More Room Based On Cash Flow Value?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Clover Health (CLOV) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPWEJkWS00NEFqOGE0UHp1a09uOXludWVNckNpUWJzbGRQZ1VJczdtRHltVXNWdThXOG91T01uVTBlMHJ3UDlyV2p4Zm96aktWNHJJamxaQ25HOTFkR3RKQ2xhRndjLU44YWxGV3oxaVdIMENTRmpVOWZHd0g4Q1ZYNl9nazJfN1JRblRocWVkekM2cnhXa2ZwMjdEZ3VwaXZhV0pjdg?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Clover Health (CLOV) Stock Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNNWYxeXE3czJtbkRHWW5EUHlLaVpyMUVjUmhjNzNsNW1GRkV0RFFFUjdGQ016UVB5bW5jb09GSzJEWnVObUhLVDdMU25NcEMtYndxU2FfN2hhNUIyeEM0NExidXhucFo3STJFRnIxVUNQZXh2Y3Z2NXlfNWpic3NpcC1aUmRRbE1mVWlLdXVTTHNpTjBzdGx6Vg?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Clover Health Investments (CLOV) Valuation As Shares Rebound Over The Past Week", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQR3VpY3h2c29WYzFseGhfd25aeUp5RXFYc3NEaEM1VVdhNm5sM0tfMURqUE5pOUVVNHdJa0JtRTZuUmZmUWdJQ2JOdjlnTko3Y0pwZDExUExKdURVZ2F3ZHV5X3Znd3RJLXp4YVRNZWczZDY3cGRzTHI2TG95QVkxQzZXQXNIS3RNRDVXMWVNMFZHM1VabGIwYjMzckhKLVlYc1E?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oscar Health will post first-quarter results before an 8 a.m. call May 6", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQTmUwelBCVmZiVHFoeVE0bkc3TmFHenRqcm16N0dhVTJuekNiaHBVMmV2TkY3THd2ZXJhcVc0cU5tQlVLcGRqYTZXaE5UbERuczFLODY0Y1VSVkYtaXZnYnBLMThLbkdHdUFrOEZ3YTk5ZU1iNHgxWWpBeXhXT1ptN1g2cXNfVDBfcFFwTF9hSmJvOFZMVUlHdjJxR1ZwbU05d0ZnZ3VKRTNQQTVfNVNn?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Issuer (NASDAQ: CLOV) plans 10,192-share Class A sale under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNSm1fSDByN2VISDBva3RlT3lKaks0WTJsdGF4ZTJjbU0wWHRvRmlzQktZZmFncGNWZXBPTzUzaHc3M21jZ0NSUnNydXBrRVRFT1pqLV82MFkwakRqTjdQMkdDSjVaU0hIQWFwMjlqblZQZ2VmUnNyWHpkTzBMczdpNXFoMXpjb1liZUhWNTNSb2RId2IyYlpWUUNnSUpsbmdMZy1haUxLR2xhR3dPTUdR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:42:10+00:00", "published_display": "15 Jul 2026 21:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sale of 12,712 shares planned in CLOV (Nasdaq: CLOV) notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQYnZFVGZnamJMMDhFcmxOQXZzNnRCcjB2c21SeTNGSjNUNmI4NERiSkdzT2tpRlN3N2czbEFQVUxkaXVBRGtMbzNtTVgxVFpBQUstc2VjQ1I4Q0x5Tkp6bHMzM014M1JiRWVVMUhHNlMwc0Njdzc5ZEFKNk51TF81d1NpbDk2MUptWDFvOWhfcHRIT0pkcEF2cVhycHpsd2pwSHNNRWVkcmI2SndqS2dz?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:38:14+00:00", "published_display": "15 Jul 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLOV (Nasdaq: CLOV) plans Rule 144 sale of 60765 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNZUZ1SjhqRkVzTjllZTFyakRBTl9OSjM4T1dleDd5Nk1yanRVYkhGWlVLOUxlTExxMFQ0WmNSRWZwbklSRVd0eTlsd2EtYTNnT3BVcGZhazRqVURNdVF2MVEwTHFjWG5oT0RpNE5zelR6V0p6NmFNYW9LYmt1LWdJdklRQVp6bDVaTXhDR1djSnd0SWVRRFNiSGVtaWR2a3dNMFBwcFJEM0lCNVZUbVpR?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:31:00+00:00", "published_display": "15 Jul 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Grab Stock And 2 Penny Stocks With Strong Financial Health", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-13T13:43:40+00:00", "published_display": "13 Jul 2026 13:43", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments (CLOV) Faces A Valuation Test Ahead Of August Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPcS1wa28ycjl4MFVvX0JDVjQ0Nzl4T1lob0dMMENkdTVCV2lWdjY5WlZwNHA0blRSaVNHTC1JdzY1b1lJUW9fd2VGRGJDbzYwZG5BRXY5VXpySkhhZFdSZTFfa1NiNGYzbVhKazQ4S05qd0FsTE45N05ITy1pdXY4U2VNU0FmVTM3eFZpMGIwWUpRRVZfWXQ1Y01tcGJROUFpRENV?oc=5", "source_name": "Market source", "published_at": "2026-07-11T05:16:03+00:00", "published_display": "11 Jul 2026 05:16", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Clover Health Investments (CLOV) Reasonable After Its 3.8x Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYzZDMUkxLWNSQ3JhRmY0SFpDdE9wQlBfN2I2UzJXN1dfWVRWMlBSR1hsVFl1MVltX3IxMVR3RDgwRXFYbG9Ha3FCV2RxR1hIUTRmOXBkbXNxRXFjRy1YUXkzZzNnMVdpZ2NzOC1Gdi02Yl9HS2xBMUJZVHd0V09VRnBZbFY3bFNTcVQ3NUtrRDNJeDlYLUl3QWUxd2ZXNi1BUVhrSWtUd2sxQQ?oc=5", "source_name": "Market source", "published_at": "2026-07-10T12:15:13+00:00", "published_display": "10 Jul 2026 12:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Medicare Advantage CEO sells $11,157 in shares", "summary": "Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp. (NASDAQ:CLOV), sold 2,384 shares of the company's Class A Common Stock for a total of $11,157 on July 8, 2026. This transaction was part of a pre-arranged trading plan. Following the sale, Reynoso sti", "url": "https://www.investing.com/news/insider-trading-news/clover-health-medicare-advantage-ceo-sells-11157-in-shares-93CH-4784970", "source_name": "Investing.com", "published_at": "2026-07-09T21:45:44", "published_display": "09 Jul 2026 21:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/clover-health-report-second-quarter-200500383.html", "source_name": "GlobeNewswire", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health sets Aug. 5 webcast for second-quarter results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPaTZlc1UxQjNSM0ZyMjhqaUNpZVVNSGl4T21ETDluSjZSbm9HWGJSVkMybVNROTFoVkU4LXFET293ckJKaFEwUlA5eXlTTnlwOTF0VUV3Rlo3RVZaWFozd3BLUnl2eDdCU3lGUFYxVU9qZ2tDU3ZGOU4zNU1OTHhSdndBWTVldWhpdDJfeWlVemhuMGtTd1JyWk5XaVR5RWZVV214TGlWX2VRRUhFeFRLckN6cGxNQ0tNTzdZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-09T20:05:00+00:00", "published_display": "09 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) Medicare Advantage CEO sells small stake under Rule 10b5-1 plan", "summary": "Clover Health Investments, Corp. CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,384 shares of Class A Common Stock at $4.68 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026, and leaves Reynoso with 2,832,598 sh", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-e8cffac469f3.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:45:44", "published_display": "09 Jul 2026 20:45", "sentiment": "negative", "sentiment_pct": 40, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Don't Ignore The Insider Selling In Clover Health Investments", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-07T07:00:00+00:00", "published_display": "07 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health's CEO Sold Company Shares Worth $1.7 Million. Here's What That Means for Investors.", "summary": "", "url": "https://finance.yahoo.com/m/70ae2e15-e70c-375b-913f-a21c367aba47/clover-health%27s-ceo-sold.html", "source_name": "Motley Fool", "published_at": "2026-07-07T00:52:01+00:00", "published_display": "07 Jul 2026 00:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jamie Reynoso 10b5-1 sales listed in CLOV Form 144 (CLOV)", "summary": "A recently filed Form 144 for Clover Health Investments, Corp. (CLOV) details multiple 10b5-1 sales by Jamie Reynoso. The filing, dated July 6, 2026, lists sales on March 18, 2026, June 11, 2026, June 15, 2026, and June 17, 2026, along with Restricted Stock Units dated July 3, 20", "url": "https://www.stocktitan.net/sec-filings/CLOV/144-clover-health-investments-corp-de-sec-filing-5d96f1e68ce5.html", "source_name": "Stock Titan", "published_at": "2026-07-07T01:12:10", "published_display": "07 Jul 2026 01:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) exec sells 6,229 shares in mandated tax-withholding trade", "summary": "Jamie L. Reynoso, CEO of Medicare Advantage for Clover Health (CLOV), sold 6,229 shares of Class A Common Stock at $5.26 per share. This transaction was not a discretionary trade but a \"sell to cover\" action to meet tax withholding obligations related to the vesting of restricted", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-1fedc3a28371.html", "source_name": "Stock Titan", "published_at": "2026-07-07T00:36:54", "published_display": "07 Jul 2026 00:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Medicare Advantage CEO Reynoso sells $32,764 in stock", "summary": "Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 6,229 shares of Class A Common Stock for $32,764 on July 6, 2026. This sale was a \"sell to cover\" transaction to fulfill tax withholding obligations tied to the vesting of restricted stock units", "url": "https://www.investing.com/news/insider-trading-news/clover-health-medicare-advantage-ceo-reynoso-sells-32764-in-stock-93CH-4777821", "source_name": "Investing.com", "published_at": "2026-07-06T22:39:54", "published_display": "06 Jul 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UBS Nearly Doubles Its Price Target on Clover Health (CLOV)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxPekhSeDBZU1dwaVJHZ3VzY193RVRVejROOWp5V3VSVXVJNU9iN0dNNTBaaTNoX0NyVFpIaHhNZ3RBRjhQclpKRjlydU5seVo2RmhOOEV6YzNUMEJRU1JsNnRJTUdxNS16S1VOZ1F3TjhCSkpmRHNoTUt5YlF1R05iRmRvUWlhN3c4WkR4a3ZWZUs5aG5jbHpB?oc=5", "source_name": "Market source", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments (CLOV) Q1 Beat And Guidance Raise Put Valuation Back In Focus", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-04T07:00:00+00:00", "published_display": "04 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Clover Health (NASDAQ:CLOV) And Health Insurance Providers Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQWjA4Rm1nS3Zwa0xJTkI4ckF6NHUyUzNHTFNEdzhJdHlRVDE2RGdUalpxaDExNVVCUHc0Yi1Mc3Q5MmJtQ1oxNFJDTG84ZVlzcUk4VFc5NTZtN0JlX1Q4S01MQ3hwM2FYV3VHSFpGeHBqUDlUbFhNRGgtZzBDbGltUzRaQWhGLW9SQVBaZ2hkeElZQ1FqQzkwck53cFhOYms?oc=5", "source_name": "Market source", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) CEO\u2019s 313,476-share sale tied to RSU tax withholding", "summary": "Clover Health Investments, Corp. (CLOV) CEO Andrew Toy sold 313,476 shares of Class A common stock at $5.32 per share. This sale was explicitly to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs) and was a non-discretionary \"sell to c", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-8147846aeb02.html", "source_name": "Stock Titan", "published_at": "2026-07-02T00:40:29", "published_display": "02 Jul 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Andrew Toy sells $1.67 million in stock By Investing.com", "summary": "Clover Health CEO Andrew Toy sold 313,476 shares of Class A Common Stock for $1.67 million to cover tax withholding obligations related to vested restricted stock units. This sale was a \"sell to cover\" transaction and not a discretionary trade. The stock, trading near its 52-week", "url": "https://ng.investing.com/news/stock-market-news/clover-health-ceo-andrew-toy-sells-167-million-in-stock-93CH-2583448", "source_name": "Investing.com Nigeria", "published_at": "2026-07-01T22:41:13", "published_display": "01 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Andrew Toy sells $1.67 million in stock", "summary": "Clover Health CEO Andrew Toy sold 313,476 shares of Class A Common Stock for $1.67 million to cover tax obligations related to restricted stock units. This sale was a mandatory \"sell to cover\" transaction and not discretionary. The company recently reported Q1 2026 revenue of $74", "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-andrew-toy-sells-167-million-in-stock-93CH-4771953", "source_name": "Investing.com", "published_at": "2026-07-01T22:40:29", "published_display": "01 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing", "summary": "This SEC filing details a Form 144 notice of proposed sale of securities for Clover Health Investments, Corp. (CLOV). The filing indicates an individual plans to sell 309,558 shares of Class A Common Stock, acquired through Restricted Stock Units as compensation, with an aggregat", "url": "https://www.stocktitan.net/sec-filings/CLOV/144-clover-health-investments-corp-de-sec-filing-033d45f7b7fa.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:39:12", "published_display": "01 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Clover Health Investments Corp. Class A Stocks", "summary": "This article provides a list of exchange-traded funds (ETFs) that hold Clover Health Investments Corp. Class A stocks. The funds are sorted by market value and include details such as issuer, management style, focus, expense ratio, assets under management (AUM), and price perform", "url": "https://www.tradingview.com/symbols/FWB-7QD/etfs/", "source_name": "TradingView", "published_at": "2026-06-30T20:09:39", "published_display": "30 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Clover Health (CLOV) Centralizing Home-Care Leadership Reveal a Deeper Shift in Strategy?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CLOV SEC Filings - Clover Health Investments Corp 10-K, 10-Q, 8-K Forms", "summary": "This page provides a comprehensive resource for investors to access Clover Health Investments (CLOV) SEC filings, including annual reports (10-K), quarterly reports (10-Q), and material event reports (8-K). It details recent insider transaction activity, such as share withholding", "url": "https://www.stocktitan.net/sec-filings/CLOV/", "source_name": "Stock Titan", "published_at": "2026-06-29T04:28:07", "published_display": "29 Jun 2026 04:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.", "summary": "", "url": "https://finance.yahoo.com/m/8f497b0a-a9d9-3007-9cd1-289260234486/a-clover-health-director-sold.html", "source_name": "Motley Fool", "published_at": "2026-06-27T17:33:01+00:00", "published_display": "27 Jun 2026 17:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "7QD Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast and price target for Clover Health Investments Corp. Class A (7QD) stock based on analyst opinions. It details maximum and minimum price estimates, historical price data, earnings information, and financial performance for the company, including re", "url": "https://www.tradingview.com/symbols/HAM-7QD/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T10:40:29", "published_display": "26 Jun 2026 10:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments Corp. Class A Actuals & Estimates (NASDAQ:CLOV)", "summary": "This article provides an overview of Clover Health Investments Corp. (NASDAQ: CLOV), detailing its financial actuals and estimates. It covers the company's current stock price, historical highs and lows, market capitalization, and volatility. Additionally, it includes analysts' f", "url": "https://www.tradingview.com/symbols/NASDAQ-CLOV/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T02:42:00", "published_display": "26 Jun 2026 02:42", "sentiment": "positive", "sentiment_pct": 63, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments Corp. Class A Actuals & Estimates (BX:CLOV)", "summary": "This article provides financial actuals and estimates for Clover Health Investments Corp. Class A (CLOV) traded on the BX Swiss exchange. It details analyst price targets, upcoming earnings dates, past earnings and revenue figures, and confirms that CLOV does not pay dividends. T", "url": "https://www.tradingview.com/symbols/BX-CLOV/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T23:09:36", "published_display": "25 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health stock hits 52-week high at 5.18 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPYVlNeFhwdlNTR3RwN2UwNWRDREpkV0Jkcllkc0U4RzVFZkZNbHB3RjVwQ1o3dFZuOVBXdllaRnBHaE5Jd2s5eDhRcU1wNlE1LTZ3RWNtU0FQRUIzYWdpWGpCUWgxZmhjR254cUROWHllZUtTZGhjTFBrRFktd051ZVhNdVJVQVJONTRXVktmaUhqUTNDejE1b0NZeHpiXzhJbnZBTi05cw?oc=5", "source_name": "Investing.com", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV): 3 Reasons We Love This Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORnFrd3YzeFFCWjc3TmdiMUhGRWJ4WHZTN2c4ejRhY0VjOUVTMlF3MFRTWGN6dmphODZ4bG44TWh2TDRieGNlblU2RE1PSEhlSUg0MExIdmt2TzBfckw3ZU1HMmlDVFNzdXVIRVNlalVrRElWZldWSlZVd3N2TFJuMUQyV2VHRzZEYkhhMzV0RjV2Nm83Q0tNaQ?oc=5", "source_name": "Market source", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $11,280 in class A stock By Investing.com", "summary": "Jamie Reynoso, CEO of Medicare Advantage at Clover Health Investments, sold 2,360 shares of Class A Common Stock worth $11,280 on June 17, 2026, as part of a Rule 10b5-1 trading plan. This sale occurred while Clover Health shares have risen 104% year-to-date and are trading near ", "url": "https://m.au.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-11280-in-class-a-stock-93CH-4494523?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-19T05:40:42", "published_display": "19 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $11,280 in class A stock", "summary": "Clover Health's CEO of Medicare Advantage, Jamie L. Reynoso, sold 2,360 shares of Class A Common Stock for a total of $11,280 on June 17, 2026, as part of a Rule 10b5-1 trading plan. This transaction occurred amidst a 104% year-to-date surge in Clover Health shares, leading to an", "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-11280-in-class-a-stock-93CH-4749420", "source_name": "Investing.com", "published_at": "2026-06-18T18:08:58", "published_display": "18 Jun 2026 18:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) executive sells 2,360 shares in 10b5-1 plan", "summary": "Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, sold 2,360 shares of Class A common stock at a weighted average price of $4.78 per share. This sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on March 12, 2026. Following th", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-2fbaac1f92bb.html", "source_name": "Stock Titan", "published_at": "2026-06-18T10:40:04", "published_display": "18 Jun 2026 10:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health VP of finance Oldakowski sells $58,815 in stock", "summary": "Joseph Frank Oldakowski, VP of Finance at Clover Health, sold 12,102 shares of Class A Common Stock for $58,815 on June 16, 2026. This transaction was a \"sell to cover\" to fulfill tax obligations for vesting restricted stock units (RSUs) and was not a discretionary trade. The sal", "url": "https://www.investing.com/news/insider-trading-news/clover-health-vp-of-finance-oldakowski-sells-58815-in-stock-93CH-4747244", "source_name": "Investing.com", "published_at": "2026-06-18T05:10:35", "published_display": "18 Jun 2026 05:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health VP of finance Oldakowski sells $58,815 in stock By Investing.com", "summary": "Joseph Frank Oldakowski, VP of Finance at Clover Health, sold 12,102 shares worth $58,815 to cover tax obligations from vested restricted stock units. This \"sell to cover\" transaction was not discretionary and occurred as Clover Health's stock is up 110% year-to-date, trading nea", "url": "https://m.au.investing.com/news/insider-trading-news/clover-health-vp-of-finance-oldakowski-sells-58815-in-stock-93CH-4492373?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-17T14:10:42", "published_display": "17 Jun 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) finance VP sells 12,102 shares in tax-related RSU transaction", "summary": "Joseph Frank Oldakowski, VP of Finance and Controller at Clover Health, sold 12,102 shares of Class A Common Stock for $4.86 per share to cover tax withholding obligations related to the vesting of restricted stock units. This \"sell to cover\" transaction was mandatory and not a d", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-60e2e3918ead.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:10:42", "published_display": "17 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $29,273 in company stock By Investing.com", "summary": "Clover Health CEO Jamie Reynoso sold 6,350 shares of the company's Class A Common Stock for $29,273 to cover tax withholding obligations related to restricted stock unit vesting. Following the sale, Reynoso directly owns 2,843,571 shares. Despite the stock trading near its 52-wee", "url": "https://au.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-29273-in-company-stock-93CH-4489885", "source_name": "Investing.com Australia", "published_at": "2026-06-16T17:09:41", "published_display": "16 Jun 2026 17:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health chief legal officer Karen Soares sells $21,579 in stock", "summary": "Clover Health's Chief Legal Officer, Karen Soares, sold 4,681 shares of the company's Class A Common Stock for a total of $21,579. These transactions were \"sell to cover\" to fulfill tax withholding obligations tied to restricted stock unit vesting, not discretionary trades. Follo", "url": "https://www.investing.com/news/insider-trading-news/clover-health-chief-legal-officer-karen-soares-sells-21579-in-stock-93CH-4744727", "source_name": "Investing.com", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) executive logs small tax-related sell-to-cover stock sale", "summary": "Clover Health Investments executive Jamie L. Reynoso, CEO of Medicare Advantage, sold 6,350 shares of Class A common stock on June 15, 2026, at a weighted average price of $4.61 per share. This sale was a non-discretionary \"sell to cover\" transaction to fulfill tax withholding ob", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-0139f8cc8af9.html", "source_name": "Stock Titan", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV) legal chief sells 4,681 shares to cover taxes", "summary": "Clover Health Investments' Chief Legal Officer, Karen Soares, sold 4,681 shares of Class A common stock at a weighted average price of approximately $4.61 per share. This was a mandated \"sell to cover\" transaction to fulfill tax obligations related to vesting restricted stock uni", "url": "https://www.stocktitan.net/sec-filings/CLOV/form-4-clover-health-investments-corp-de-insider-trading-activity-b9ac876d15cb.html", "source_name": "Stock Titan", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health CEO Jamie Reynoso sells $29,273 in company stock", "summary": "Clover Health CEO Jamie Reynoso sold 6,350 shares of Class A Common Stock, totaling $29,273, to cover tax withholding obligations related to restricted stock units. This \"sell to cover\" transaction, occurring at a weighted average price of $4.61 per share, was not a discretionary", "url": "https://www.investing.com/news/insider-trading-news/clover-health-ceo-jamie-reynoso-sells-29273-in-company-stock-93CH-4744728", "source_name": "Investing.com", "published_at": "2026-06-16T12:40:20", "published_display": "16 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Court Win Lifts Clover Health Star Rating And Future Revenue Potential", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health stock jumps after Medicare rating upgrade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOM0Y0RjY1ZlJTNUJzeWlMbnpFSk5PdVl0NWRsM3ZqRHRlZFVocmlwS2xENnlGbmloTVFVcGNlY3MxdnQ0VTZKd29HdUozVk10WXdaRzdXQzZ1S25IX0xWV01vaTBzNk9JVTVHT0dTd0RVYU9qcnpmTTRhZ0JtdHN0dUxIa2hoX3MxeElIajBVYm91ZVhoWlpQVGE2UzVGVGVRWUlSUDUwWDJTSDBRWWg4dUhDR1p5WHBO?oc=5", "source_name": "Investing.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health (CLOV)Hits Fresh Peak on Unexpected CMS Rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxQX0VHQ0xBTUpwYlhJQW04QkRPWHpnZzhRZm9VM0RYZDFYYzJfMjAxVTZyMlRYeFVJN25YTEw5dXh2QjNocmtiazRGX2xrMmN0WVF6QjgyamMzeUNicENRQWdLbmpUUmRhX0xQbWxLclRpMFlSeGd3UGtaQkFjVVp3ZlV0aFhCczljYVB2cmgyNDdnN1BmWG9RMDNB?oc=5", "source_name": "Market source", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover stock slips after robust Thursday gain", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOclhsV21iRUNkcmZFT09hREhHeG5WdG5CMjdkdGlYVkUySDNZQ0dVUEV4YWpVbEhDRng4dVRPM2F0T0wzZFZjNGhFbTcyT3UzbExRZFVOWlpfcENTdzhWVkl3MGVLRnN0QUdYR2tHaDlabkZZdUFHRUpjMU5EZ2hPSzZqVXhDSHlBVnhEUkRPTk41Z1dfMWd6OGxqeERsUDl5eUtjMHo1Sk5tU3FOaWVmOW1NUjJpU3JLSW16Zi01OVVyVVhiN21rN3E0U3B0MHNZdFEyMDMxLVBOT3IxWEFJ?oc=5", "source_name": "Nashville Post", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clover Health Investments And 2 Other Insider Picks For Growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONkFGQmZld3ctd0tDYkNQY3JZMFYzS2FHaTFueThreVJxdmFMZThfa2FOZkctSFRwVWhubjkybGxiWEJ6c0tsQ0RlZk94OGhRNXlUZUh5QmdJS1VkQWU4MDU5QkVUOW1yQzB0SjFxYW53dk9UbnFTdmpxSE1hTzk2Z25LT3JncnJMblBhZ3phc0ExVlJNdUhPLWVFRWoxdEE?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Has Clover Health Investments (CLOV) Share Surge Left More Room Based On Cash Flow Value?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Clover Health (CLOV) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPWEJkWS00NEFqOGE0UHp1a09uOXludWVNckNpUWJzbGRQZ1VJczdtRHltVXNWdThXOG91T01uVTBlMHJ3UDlyV2p4Zm96aktWNHJJamxaQ25HOTFkR3RKQ2xhRndjLU44YWxGV3oxaVdIMENTRmpVOWZHd0g4Q1ZYNl9nazJfN1JRblRocWVkekM2cnhXa2ZwMjdEZ3VwaXZhV0pjdg?oc=5", "source_name": "StockStory", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Clover Health (CLOV) Stock Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxNNWYxeXE3czJtbkRHWW5EUHlLaVpyMUVjUmhjNzNsNW1GRkV0RFFFUjdGQ016UVB5bW5jb09GSzJEWnVObUhLVDdMU25NcEMtYndxU2FfN2hhNUIyeEM0NExidXhucFo3STJFRnIxVUNQZXh2Y3Z2NXlfNWpic3NpcC1aUmRRbE1mVWlLdXVTTHNpTjBzdGx6Vg?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Clover Health Investments (CLOV) Valuation As Shares Rebound Over The Past Week", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQR3VpY3h2c29WYzFseGhfd25aeUp5RXFYc3NEaEM1VVdhNm5sM0tfMURqUE5pOUVVNHdJa0JtRTZuUmZmUWdJQ2JOdjlnTko3Y0pwZDExUExKdURVZ2F3ZHV5X3Znd3RJLXp4YVRNZWczZDY3cGRzTHI2TG95QVkxQzZXQXNIS3RNRDVXMWVNMFZHM1VabGIwYjMzckhKLVlYc1E?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Oscar Health will post first-quarter results before an 8 a.m. call May 6", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQTmUwelBCVmZiVHFoeVE0bkc3TmFHenRqcm16N0dhVTJuekNiaHBVMmV2TkY3THd2ZXJhcVc0cU5tQlVLcGRqYTZXaE5UbERuczFLODY0Y1VSVkYtaXZnYnBLMThLbkdHdUFrOEZ3YTk5ZU1iNHgxWWpBeXhXT1ptN1g2cXNfVDBfcFFwTF9hSmJvOFZMVUlHdjJxR1ZwbU05d0ZnZ3VKRTNQQTVfNVNn?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 82, "total_relevant": 52, "sentiment_summary": {"positive": 9, "negative": 2, "neutral": 41, "score": 52, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 20.9, "count": 38}, {"event": "earnings", "label": "Earnings", "weight": 3.85, "count": 7}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 9, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 4.44, "latest_week": "2026-07-10", "one_week_move": -15.6, "four_week_move": -6.1, "twelve_week_move": 102.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.264107, "market_dynamics_buy_signal": false, "relative_strength": 35.168054, "fair_value_gap": 84.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 51.8652, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-15.6% over one week, -6.1% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 15}, {"label": "Market source", "count": 9}, {"label": "Investing.com", "count": 9}, {"label": "simplywall.st", "count": 6}, {"label": "TradingView", "count": 4}, {"label": "Investing.com Australia", "count": 3}, {"label": "Motley Fool", "count": 2}, {"label": "GlobeNewswire", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 38}, {"label": "Earnings", "count": 7}, {"label": "Analyst action", "count": 4}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-15.6% over one week, -6.1% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Issuer (NASDAQ: CLOV) plans 10,192-share Class A sale under 10b5-1 plan"}], "updated_at": "2026-07-16T05:28:42.151909+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}